| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |